Cameron is top CAT
Executive Summary
AstraZeneca subsidiary Cambridge Antibody Technology appointed former AZ Head of Cardiovascular Therapy Area and Head of Medical Research Hamish Cameron as Chief Executive of CAT Limited, effective immediately, the company announced June 22. AstraZeneca acquired the biotech company as part of broader efforts to develop its biopharmaceuticals portfolio (1"The Pink Sheet" June 19, 2006, p. 9)...